Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Number of holders
-
2,473
-
Total 13F shares, excl. options
-
1,307,462,033
-
Shares change
-
+2,992,764
-
Total reported value, excl. options
-
$143,116,956,354
-
Value change
-
+$331,022,292
-
Put/Call ratio
-
91%
-
Number of buys
-
1,018
-
Number of sells
-
-973
-
Price
-
$109.49
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q4 2020
2,597 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q4 2020.
ABBOTT LABORATORIES - Common Stock (ABT) has 2,473 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,307,462,033 shares
of 1,740,239,592 outstanding shares and own 75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (147,272,920 shares), BlackRock Inc. (133,426,810 shares), Capital Research Global Investors (86,394,199 shares), STATE STREET CORP (71,331,163 shares), Capital International Investors (53,591,471 shares), WELLINGTON MANAGEMENT GROUP LLP (31,182,319 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27,096,608 shares), MORGAN STANLEY (26,687,412 shares), NORTHERN TRUST CORP (26,424,385 shares), and GEODE CAPITAL MANAGEMENT, LLC (25,640,832 shares).
This table shows the top 2,473 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.